 progression AIDS combined usefulness lymphocyte counts antigenemia PURPOSE combined usefulness lymphocyte counts human immunodeficiency virus type antigen progression immunodeficiency syndrome AIDS PATIENTS METHODS lymphocyte counts antigen status period men Multicenter AIDS Cohort Study Chicago RESULTS Twenty-six percent cohort detectable antigen study period Men antigenemia rapid decline lymphocyte counts men antigen-negative Mean lymphocyte counts first detection antigen cells/microL men incident prevalent antigenemia Antigen men AIDS men estimated cumulative AIDS incidence men entry cells/microL Presence antigenemia rapid disease progression groupings CONCLUSION data antigenemia moderate cell depletion rapid decline lymphocyte population lymphocyte counts useful individuals risk disease progression findings important information disease prognosis period